Trial Profile
Escitalopram in the Long-term Treatment of Major Depressive Disorder With Associated Anxiety Symptom
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Xian-Janssen
- 26 Mar 2013 New trial record